Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7682425rdf:typepubmed:Citationlld:pubmed
pubmed-article:7682425lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:7682425lifeskim:mentionsumls-concept:C0682458lld:lifeskim
pubmed-article:7682425lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:7682425lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:7682425lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:7682425lifeskim:mentionsumls-concept:C0003261lld:lifeskim
pubmed-article:7682425lifeskim:mentionsumls-concept:C0596032lld:lifeskim
pubmed-article:7682425lifeskim:mentionsumls-concept:C0449774lld:lifeskim
pubmed-article:7682425lifeskim:mentionsumls-concept:C1519878lld:lifeskim
pubmed-article:7682425pubmed:issue3lld:pubmed
pubmed-article:7682425pubmed:dateCreated1993-5-14lld:pubmed
pubmed-article:7682425pubmed:abstractTextThe principal neutralizing domain (PND) of HIV-1, located within the third variable region (V3) of the gp120 envelope protein, is related to the humoral and cellular immune response. We studied the V3 PND-specific antibody response in 30 children with vertically acquired HIV-1 infection by determining the antibodies that bound synthetic peptides derived from the PND of the HIV-1MN, HIV-1SF-2, HIV-1SC, HIV-1IIIB, HIV-1RF, HIV-1ELI, and HIV-1Z6 virus strains. At a standard antigen concentration, we found that most sera (90%) reacted against PNDMN peptide, but 73.3% also cross-reacted against multiple PNDs. A search for high-affinity/avidity antibodies was conducted in an antigen-limited assay; at lower peptide concentrations, cross-reactivity was restricted to PNDMN and PNDSC in 12 of 22 broadly reactive sera. Sequence analysis of the V3 region of HIV-1 isolates indicated that patients with high-affinity/avidity antibodies to PNDMN and PNDSC had a PND with an internal 12-amino acid sequence (serotype-specific domain, SSD) that was highly homologous (> 90%) with the MN and SC SSD. Broadly reactive sera with low-affinity/avidity antibodies showed a lower degree of homology with the SSD sequence of all tested viral strains. The role of anti-PND antibodies in vertical transmission was further studied in 49 children born to HIV-1-seropositive mothers. No statistical correlation emerged between V3 antibodies and HIV-1 transmission, but we found that maternal V3 antibodies were lost soon after birth. This finding may be relevant to a new serological approach to the early diagnosis of vertically transmitted HIV-1 infection.lld:pubmed
pubmed-article:7682425pubmed:languageenglld:pubmed
pubmed-article:7682425pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7682425pubmed:citationSubsetIMlld:pubmed
pubmed-article:7682425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7682425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7682425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7682425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7682425pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7682425pubmed:statusMEDLINElld:pubmed
pubmed-article:7682425pubmed:monthMarlld:pubmed
pubmed-article:7682425pubmed:issn0889-2229lld:pubmed
pubmed-article:7682425pubmed:authorpubmed-author:Chieco-Bianch...lld:pubmed
pubmed-article:7682425pubmed:authorpubmed-author:De RossiAAlld:pubmed
pubmed-article:7682425pubmed:authorpubmed-author:Del MistroAAlld:pubmed
pubmed-article:7682425pubmed:authorpubmed-author:MammanoFFlld:pubmed
pubmed-article:7682425pubmed:authorpubmed-author:OmettoLLlld:pubmed
pubmed-article:7682425pubmed:authorpubmed-author:ZanottiEElld:pubmed
pubmed-article:7682425pubmed:issnTypePrintlld:pubmed
pubmed-article:7682425pubmed:volume9lld:pubmed
pubmed-article:7682425pubmed:ownerNLMlld:pubmed
pubmed-article:7682425pubmed:authorsCompleteYlld:pubmed
pubmed-article:7682425pubmed:pagination221-8lld:pubmed
pubmed-article:7682425pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7682425pubmed:meshHeadingpubmed-meshheading:7682425-...lld:pubmed
pubmed-article:7682425pubmed:meshHeadingpubmed-meshheading:7682425-...lld:pubmed
pubmed-article:7682425pubmed:meshHeadingpubmed-meshheading:7682425-...lld:pubmed
pubmed-article:7682425pubmed:meshHeadingpubmed-meshheading:7682425-...lld:pubmed
pubmed-article:7682425pubmed:meshHeadingpubmed-meshheading:7682425-...lld:pubmed
pubmed-article:7682425pubmed:meshHeadingpubmed-meshheading:7682425-...lld:pubmed
pubmed-article:7682425pubmed:meshHeadingpubmed-meshheading:7682425-...lld:pubmed
pubmed-article:7682425pubmed:meshHeadingpubmed-meshheading:7682425-...lld:pubmed
pubmed-article:7682425pubmed:meshHeadingpubmed-meshheading:7682425-...lld:pubmed
pubmed-article:7682425pubmed:meshHeadingpubmed-meshheading:7682425-...lld:pubmed
pubmed-article:7682425pubmed:meshHeadingpubmed-meshheading:7682425-...lld:pubmed
pubmed-article:7682425pubmed:meshHeadingpubmed-meshheading:7682425-...lld:pubmed
pubmed-article:7682425pubmed:meshHeadingpubmed-meshheading:7682425-...lld:pubmed
pubmed-article:7682425pubmed:meshHeadingpubmed-meshheading:7682425-...lld:pubmed
pubmed-article:7682425pubmed:year1993lld:pubmed
pubmed-article:7682425pubmed:articleTitlePattern of antibody response against the V3 loop in children with vertically acquired immunodeficiency virus type 1 (HIV-1) infection.lld:pubmed
pubmed-article:7682425pubmed:affiliationInstitute of Oncology, University of Padua, Italy.lld:pubmed
pubmed-article:7682425pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7682425pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7682425lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7682425lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7682425lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7682425lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7682425lld:pubmed